Mode
Text Size
Log in / Sign up

Osteomyelitis

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Osteomyelitis

8 trials tracked for Osteomyelitis: 1 in phase 3 or 4.

8Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 1 Phase 2 4 Other / NA 3
  1. Phase 3 Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis. Completed
  2. Phase 2 Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis Completed
  3. Phase 2 Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children Completed
  4. Phase 2 Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI Completed
  5. Phase 2 Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci Completed
  6. N/A Acinetobacter Baumannii-related Osteomyelitis: Clinical and Epidemiological Characterization Completed
Show 2 more trials
  1. N/A Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections Completed
  2. N/A PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Osteomyelitis

How does delayed treatment affect children with sickle cell and osteomyelitis?

Delayed treatment in children with sickle cell disease and osteomyelitis increases risks of bone damage, infection spread, and severe complications like sepsis.

Full answer →
Does sickle cell disease make pediatric osteomyelitis harder to treat?

Yes, sickle cell disease makes pediatric osteomyelitis harder to treat due to increased risk of atypical infections like Salmonella, diagnostic challenges from overlapping symptoms, and higher complication rates.

Full answer →
What are the challenges of managing skull-base osteomyelitis?

Skull-base osteomyelitis (SBO) is a potentially fatal infection that is difficult to manage due to complex diagnosis, biofilm formation by bacteria, and the need for multi-specialty coordination.

Full answer →